349 related articles for article (PubMed ID: 34081791)
1. Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
Ishii R; Schwedt TJ; Dumkrieger G; Lalvani N; Craven A; Goadsby PJ; Lipton RB; Olesen J; Silberstein SD; Burish MJ; Dodick DW
Headache; 2021 Jul; 61(7):992-1003. PubMed ID: 34081791
[TBL] [Abstract][Full Text] [Related]
2. Photophobia Contributes to Migraine-Associated Disability and Reduced Work Productivity: Results From the American Registry for Migraine Research (ARMR).
Leibovit-Reiben Z; Dumkrieger G; Dodick DW; Digre K; Chong CD; Trivedi M; Schwedt TJ
J Neuroophthalmol; 2024 Jun; 44(2):259-266. PubMed ID: 37581595
[TBL] [Abstract][Full Text] [Related]
3. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
Pearl TA; Dumkrieger G; Chong CD; Dodick DW; Schwedt TJ
Headache; 2020 Oct; 60(9):1910-1919. PubMed ID: 32749685
[TBL] [Abstract][Full Text] [Related]
4. Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.
Ford JH; Ye W; Ayer DW; Mi X; Bhandari S; Buse DC; Lipton RB
J Patient Rep Outcomes; 2023 Apr; 7(1):34. PubMed ID: 37016181
[TBL] [Abstract][Full Text] [Related]
5. Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.
Seng EK; Singer AB; Metts C; Grinberg AS; Patel ZS; Marzouk M; Rosenberg L; Day M; Minen MT; Lipton RB; Buse DC
Headache; 2019 Oct; 59(9):1448-1467. PubMed ID: 31557329
[TBL] [Abstract][Full Text] [Related]
6. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
7. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
Bigal ME; Rapoport AM; Lipton RB; Tepper SJ; Sheftell FD
Headache; 2003 Apr; 43(4):336-42. PubMed ID: 12656704
[TBL] [Abstract][Full Text] [Related]
8. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
10. Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms.
Stewart WF; Lipton RB; Kolodner K
Headache; 2003 Mar; 43(3):258-65. PubMed ID: 12603645
[TBL] [Abstract][Full Text] [Related]
11. Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
Lipton RB; Lee L; Saikali NP; Bell J; Cohen JM
J Manag Care Spec Pharm; 2020 Oct; 26(10):1344-1352. PubMed ID: 32678720
[TBL] [Abstract][Full Text] [Related]
12. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
Buse DC; Yugrakh MS; Lee LK; Bell J; Cohen JM; Lipton RB
J Manag Care Spec Pharm; 2020 Oct; 26(10):1334-1343. PubMed ID: 32678721
[TBL] [Abstract][Full Text] [Related]
13. Pain characteristics of the acute migraine attack.
Kelman L
Headache; 2006 Jun; 46(6):942-53. PubMed ID: 16732840
[TBL] [Abstract][Full Text] [Related]
14. Specific cognitive and psychological alterations are more strongly linked to increased migraine disability than chronic migraine diagnosis.
Castro Zamparella T; Carpinella M; Peres M; Cuello FP; Maza P; Van Gansen M; Filipchuk M; Balaszczuk V; Maldonado C; Scarnato P; Conci Magris D; Lisicki M
J Headache Pain; 2024 Mar; 25(1):37. PubMed ID: 38486142
[TBL] [Abstract][Full Text] [Related]
15. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia.
Wong LP; Alias H; Bhoo-Pathy N; Chung I; Chong YC; Kalra S; Shah ZUBS
J Headache Pain; 2020 Jun; 21(1):68. PubMed ID: 32513174
[TBL] [Abstract][Full Text] [Related]
16. The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research.
Leibovit-Reiben Z; Ishii R; Dodick DW; Dumkrieger G; Cortez MM; Brennan KC; Digre K; Schwedt TJ
Headache; 2022 May; 62(5):566-576. PubMed ID: 35593782
[TBL] [Abstract][Full Text] [Related]
17. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
Ford JH; Kurth T; Starling AJ; Ayer DW; Wietecha LA; Port MD; Rettiganti M; Ruff DD
Headache; 2020 Nov; 60(10):2304-2319. PubMed ID: 33249580
[TBL] [Abstract][Full Text] [Related]
18. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
19. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers.
Stewart WF; Lipton RB; Kolodner K; Liberman J; Sawyer J
Cephalalgia; 1999 Mar; 19(2):107-14; discussion 74. PubMed ID: 10214536
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
